Abstract | BACKGROUND: CASE-DIAGNOSIS/TREATMENT: Four months after this patient received his first RTX infusion, there was a progressive and sustained decrease of immunoglobulin (Ig)G and IgM levels. Thirteen months after the initiation of RTX therapy he was in sustained remission without any steroid or oral immunosuppressive therapy; however, B cell depletion was still present. At this time he developed a fulminant myocarditis due to enterovirus. Despite aggressive treatment and the administration of intravenous polyvalent immunoglobulins there was no clinical improvement. He successfully underwent heart transplant surgery. CONCLUSIONS: We conclude that B cell depletion with RTX is efficacious in the treatment of paediatric SDNS but that it may be associated with severe infectious complications. Therefore, we recommend a close monitoring of Ig levels in children who have received RTX therapy and a supplementation with intravenous Ig as soon as the Ig levels fall below the lower limit of the normal range.
|
Authors | Anne-Laure Sellier-Leclerc, Emre Belli, Valérie Guérin, Peter Dorfmüller, Georges Deschênes |
Journal | Pediatric nephrology (Berlin, Germany)
(Pediatr Nephrol)
Vol. 28
Issue 9
Pg. 1875-9
(Sep 2013)
ISSN: 1432-198X [Electronic] Germany |
PMID | 23700173
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD19
- Immunoglobulin G
- Immunosuppressive Agents
- Rituximab
- Prednisolone
|
Topics |
- Antibodies, Monoclonal, Murine-Derived
(adverse effects, therapeutic use)
- Antigens, CD19
(metabolism)
- B-Lymphocytes
(drug effects)
- Child
- Flow Cytometry
- Heart Transplantation
- Humans
- Immunoglobulin G
(analysis)
- Immunosuppressive Agents
(adverse effects, therapeutic use)
- Male
- Myocarditis
(complications, surgery, virology)
- Myocardium
(pathology)
- Nephrotic Syndrome
(complications, drug therapy)
- Prednisolone
(therapeutic use)
- Rituximab
|